Tumor Necrosis Factor Receptor Superfamily, Member 11a, NFKB Activator (TNFRSF11A) (AA 326-616) antibody

Details for Product No. ABIN121295
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Synonyms FEO, OFE, ODFR, OSTS, PDB2, RANK, CD265, OPTB7, TRANCER, LOH18CR1, Ly109, Rank, TRANCE-R, mRANK, RGD1563614, TNFRSF11A
AA 326-616
(1), (1), (1), (1), (1), (1)
Human, Mouse (Murine)
(22), (7), (5)
(18), (8), (3), (2)
Clonality (Clone)
Monoclonal ()
(3), (1), (1)
Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
(24), (24), (8), (7), (5), (4), (4), (4), (2), (2), (1), (1)
Pubmed 6 references available
Catalog no. ABIN121295
Quantity 0.1 mg
500.50 $   Plus shipping costs $45.00
Shipping to United States (Change)
Availability Discontinued
Add to Basket

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen Fusion protein containing Amino Acid residues 326-616 of human RANK
Clone 9A725
Isotype IgG1
Purification Protein G Chromatography.
Alternative Name CD265 / RANK
Background Apoptosis, or programmed cell death, occurs during normal cellular differentiation and development of multicellular organisms. Apoptosis is induced by certain cytokines including TNF and Fas ligand of the TNF family through their death domain containing receptors, TNFR1 and Fas. Receptor activator of NF-kB (RANK) is a recently cloned member of the TNFR superfamily with no significant homology to other members of this family (1). RANK ligand (RANKL/TRANCE/ OPGL) binds to RANK on dendritic cells, upregulates the expression of anti- apoptotic protein BcL-XL suggesting a role in dendritic cell survival (2). The cytoplasmic domain of RANK interacts with TRAF2, TRAF5 and TRAF6 (3,4). Overexpression of RANK activates NF-kB and c-Jun-terminal kinase (JNK) pathways (3). Recent studies have shown that RANK interaction with TRAF6 activates NF-kB, whereas JNK activation is mediated through binding of RANK to TRAF2 (4). Alternate Names: TNFRSF11A, Receptor Activator of NF-KB, Osteoclast Differentiation Factor receptor, ODFR, Tumor Necrosis Factor Receptor Superfamily Member 11A.
UniProt Q9Y6Q6
Application Notes Flow cytometric analysis on cell surface (6). Immunohistochemistry on Paraffin sections (Ref5, see also Protocol below). Western Blot (1-2 ug/ml): Raw 264 Cells can be used as positive control, detects a protein of approx. 97 kDa. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions For Research Use only
Format Liquid
Concentration 0.5 mg/mL
Buffer PBS containing 0.05% BSA as stabilizer and 0.05% Sodium Azide as preservative.
Preservative Sodium azide
Storage 4 °C/-20 °C
Storage Comment Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf Life: One year from despatch.
Expiry Date 12 months
Supplier Images
anti-Tumor Necrosis Factor Receptor Superfamily, Member 11a, NFKB Activator (TNFRSF11A) (AA 326-616) antibody Western blot analysis of RANK in 293 cells transfected with RANK cDNA. A single protein band with an approximate mol. wt. of 97 kDa is detected.
anti-Tumor Necrosis Factor Receptor Superfamily, Member 11a, NFKB Activator (TNFRSF11A) (AA 326-616) antibody (2) Flow analysis of RANK in RAW cells using 2ug of ABIN121295. Shaded histogram represents RAW cells without antibody, green represents isotype control, purple represents anti-RANK antibody.
General Anderson, Maraskovsky, Billingsley et al.: "A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function." in: Nature, Vol. 390, Issue 6656, pp. 175-9, 1997 (PubMed).

Wong, Josien, Lee et al.: "TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor." in: The Journal of experimental medicine, Vol. 186, Issue 12, pp. 2075-80, 1998 (PubMed).

Darnay, Haridas, Ni et al.: "Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase." in: The Journal of biological chemistry, Vol. 273, Issue 32, pp. 20551-5, 1998 (PubMed).

Darnay, Ni, Moore et al.: "Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif." in: The Journal of biological chemistry, Vol. 274, Issue 12, pp. 7724-31, 1999 (PubMed).

Fiumara, Snell, Li et al.: "Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines." in: Blood, Vol. 98, Issue 9, pp. 2784-90, 2001 (PubMed).

Bharti, Takada, Shishodia et al.: "Evidence that receptor activator of nuclear factor (NF)-kappaB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-kappaB-independent and TRAF6-dependent mechanism." in: The Journal of biological chemistry, Vol. 279, Issue 7, pp. 6065-76, 2004 (PubMed).

Hosts (18), (8), (3), (2)
Reactivities (22), (7), (5)
Applications (24), (24), (8), (7), (5), (4), (4), (4), (2), (2), (1), (1)
Conjugates (3), (1), (1)
Epitopes (1), (1), (1), (1), (1), (1)
back to top